Healthcare & Life Sciences
Weekly Roundup
Index Brief — Healthcare & Life Sciences
Healthcare Policy and Pharmaceutical Sector Update: February 2 – February 8, 2026
This report provides an intelligence-grade overview of significant developments in healthcare policy, Ayushman Bharat, pharmaceuticals, digital health, and initiatives by the National Health Authority and Ministry of Health and Family Welfare between February 2 and February 8, 2026.
| 15,733 | 8.79 Crore | 89% | 603 |
|---|---|---|---|
| Private Hospitals Empanelled | New ABHA Cards in FY26 | Institutional Deliveries | Banned Drug Formulations |
Snapshot of the Week’s Highest-Impact Updates:
- The Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) expanded its private hospital network to over 15,700 facilities, with significant growth in digital health records as 8.79 crore ABHA cards were created in the current fiscal year.
- New regulations under the Drugs Rules, 1945, including mandatory QR codes for top 300 drug brands and Active Pharmaceutical Ingredients, along with revised Schedule M for Good Manufacturing Practices, reinforce pharmaceutical quality and combat counterfeit drugs.
- India launched its National Action Plan on Antimicrobial Resistance 2.0 …
Download Full Intelligence Brief (PDF)
Sign in to your PolicyIndex account to download the complete executive-ready PDF report including all policy exhibits, data tables, and strategic recommendations.
Log In to Download PDF Brief →